Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2014, Vol. 34 Issue (3): 84-90    DOI: 10.13523/j.cb.20140312
技术与方法     
逆转录法筛选mRNA靶点设计核酶对GPA的表达干预实验研究
付辉1,2, 李菲菲2, 马琼2, 付怀秀2, 崔玉芳2, 毛建平2
1. 安徽医科大学 合肥 230032;
2. 军事医学科学院放射与辐射医学研究所 北京 100850
Experimental Screening mRNA Targets by Reverse Transcription for Ribozyme to GPA Expression Interference
FU Hui1,2, LI Fei-fei2, MA Qiong2, FU Huai-xiu2, CUI Yu-fang2, MAO Jian-ping2
1. Medical University of Anhui, Hefei 230032, China;
2. Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China
 全文: PDF(1473 KB)   HTML
摘要:

采用自行设计5’固定3’随机的文库对基因mRNA进行杂交用于逆转录反应以筛选mRNA的寡核苷酸结合靶点。对人I型跨膜糖蛋白—血型糖蛋白A (glycophorin A,GPA)的mRNA筛选了4个反义寡核苷酸可结合靶点,分别设计反义核酸(Antisense),分别加入mRNA中用RNase H验证各靶点的核酸结合和切割效率,最终确定2个高效结合和切割靶点。再设计Ribozyme,构建表达核酶(Ribozyme)质粒,利用慢病毒(Lentivirus)包装技术,感染人源红系白血病细胞株K562细胞,在细胞水平验证其下调GPA基因表达的效果,对转染细胞mRNA进行反转录和Real Time PCR分析mRNA表达水平,并在蛋白水平进行了Western Blot分析。结果表明文库结合逆转录方法筛选靶点设计的Ribozyme具有高效率下调膜受体表达的作用,GPA为I型跨膜糖蛋白,该实验为筛选mRNA靶点提供参考方法,并对膜受体表达干预有参考价值。

关键词: 血型糖蛋白AmRNA靶点Ribozyme慢病毒K562细胞    
Abstract:

An oligodeoxynucleotide library which the sequence were defined at 5 prime and randomized at 3 prime was employed to screen mRNA accessible targets, in reverse transcription and PCR after hybridized the library with mRNA. The mRNA of Glycophorin A(GPA), type I transmembrane glycoprotein, was screened and obtained 4 targets sequences. Accordingly 4 antisense nucleic acids designed respectively, the binding efficiency of every target were verified by using RNase H with antisense nucleic acids. Among them 2 targets showed better effects on binding and cutting. Designed 2 ribozymes to these targets, packaged in lentivirus system, then infected K562 cells(human erythroid leukemia line), the down-regulation effect of gene expression was validated by Real Time RT-PCR and by Western Blot. It was found that the screened targets showed the best effective knocking down effects on gene expression. The study provided a reference for mRNA targets screening and Ribozyme design, and was helpful in membrane receptor expression interference, since GPA is a transmembrane protein.

Key words: Glycophorin A    mRNA    Target    Ribozyme    Lentivirus    K562
收稿日期: 2014-01-21 出版日期: 2014-03-25
ZTFLH:  Q522  
基金资助:

国家自然科学基金资助项目(81072565,30271546)

通讯作者: 毛建平     E-mail: maojp@nic.bmi.ac.cn
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
付辉
李菲菲
马琼
付怀秀
崔玉芳
毛建平

引用本文:

付辉, 李菲菲, 马琼, 付怀秀, 崔玉芳, 毛建平. 逆转录法筛选mRNA靶点设计核酶对GPA的表达干预实验研究[J]. 中国生物工程杂志, 2014, 34(3): 84-90.

FU Hui, LI Fei-fei, MA Qiong, FU Huai-xiu, CUI Yu-fang, MAO Jian-ping. Experimental Screening mRNA Targets by Reverse Transcription for Ribozyme to GPA Expression Interference. China Biotechnology, 2014, 34(3): 84-90.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20140312        https://manu60.magtech.com.cn/biotech/CN/Y2014/V34/I3/84

[1] 周颖, 毛建平. Ribozyme和DNAzyme的基因治疗实验应用进展. 中国生物工程杂志, 2010, 30(6): 122-129. Zhou Y, Mao J P. Pre-clinical application and perspective of ribozyme and DNAzyme. Chin Biotechnology, 2010, 30(6): 122-129.
[2] Rayburn E R, Zhang R W. Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible? Drug Discov Today, 2008, 13(11-12): 513-521.
[3] 吴启家, 黄林, 张翼. 催化RNA的结构与功能. 中国科学C辑: 生命科学, 2009, 39(1): 78-90. Wu Q J, Huang L, Zhang Y. Science in China Press, 2009, 39(1): 78-90.
[4] 王全会, 毛建平. mRNA靶点筛选方法研究进展. 中国生物工程杂志, 2003, 23(3):1-5. Wang Q H, Mao J P. Progress of RNA target sites screening. Chin Biotechnology, 2003, 23(3):1-5.
[5] Southern E M, Case Green S C, Elder S C, et al. Arrays of complimentary oligonucleotides for analyzing the hybridization behaviour of nucleic acids. Nucleic Acids Res, 1994, 22, 1368-1373.
[6] Milner N, Mir K U, Southern E M. Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nat Biotechnol, 1997, 15, 537-541.
[7] Pan Wei hua, Heidi F D, Colleen K, et al.A selection system for identifying accessible sites in target RNAs.RNA, 2001, (7): 610-621
[8] Hatim T, Fang Dong, Hon S I, et al. Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase.RNA. 2001, (7):314-327
[9] Ilka B, Annette G B. Illuminating the life of GPCRs. Cell Commun Signal, 2009;7:16-19.
[10] 毛建平, 王全会, 施水兰, 等. 绿色荧光蛋白基因mRNA反义寡核苷酸的筛选和应用. 中国生物化学与分子生物学报, 2005, 21(49):529-536. Mao J P, Wang Q H, Shi SH L, et al. Application of antisense oligonucleotides designed to screened green fluorescence protein mRNA accessible sites. Chin J Biochem Mol Biol, 2005, 21(49):529-536.
[11] 毛建平, 毛秉智. 基因药物研究现状和对策. 中国生物化学与分子生物学报, 2004, 20(2): 143-148. Mao J P, Mao B ZH. Advannces and strategies in gene drugs development. Chin J Biochem Mol Biol, 2004, 20(2): 143-148.
[12] Podbielska M, Krotkiewski H.Identification of blood group A and B antigens in human glycophorin. Arch Immunol Ther Exp, 2000, 48(3):211-218.

[1] 赵晓煜,徐祺玲,赵晓东,安云飞. 基因治疗慢病毒载体的转导增强策略*[J]. 中国生物工程杂志, 2021, 41(8): 52-58.
[2] 钱昱,丁晓雨,刘志强,袁增强. 基因修饰人多能干细胞的高效单克隆建系方法[J]. 中国生物工程杂志, 2021, 41(8): 33-41.
[3] 刘少金,冯雪娇,王俊姝,肖正强,程平生. 我国核酸药物市场分析及对策建议[J]. 中国生物工程杂志, 2021, 41(7): 99-109.
[4] 陈文洁,苗先锋. 抗体偶联药物国内研发现状及企业布局分析[J]. 中国生物工程杂志, 2021, 41(6): 105-110.
[5] 陶守松,任广明,尹荣华,杨晓明,马文兵,葛志强. 敲低去泛素化酶USP13抑制K562细胞的增殖*[J]. 中国生物工程杂志, 2021, 41(5): 1-7.
[6] 杨若南,许丽,徐萍,苏燕. RNA疗法产业发展态势分析及建议 *[J]. 中国生物工程杂志, 2021, 41(2/3): 162-171.
[7] 黄胜, 严启滔, 熊仕琳, 彭弈骐, 赵蕊. 基于CRISPR/Cas9-SAM系统CHD5基因过表达慢病毒载体的构建及对膀胱癌T24细胞增殖,迁移和侵袭能力的影响 *[J]. 中国生物工程杂志, 2020, 40(3): 1-8.
[8] 曹萌,赵宇豪,郭中平. 从国际非专利名称纵观全球生物药发展[J]. 中国生物工程杂志, 2020, 40(1-2): 154-165.
[9] 井汇源,段二珍,董望. 体外转录的自我复制型mRNA疫苗研究进展*[J]. 中国生物工程杂志, 2020, 40(12): 25-30.
[10] 菅璐,黄映辉,梁天亚,王利敏,马洪涛,张婷,李丹阳,王明连. 利用CRISPR/Cas9技术建立敲除JAK2基因K562细胞系 *[J]. 中国生物工程杂志, 2019, 39(7): 39-47.
[11] 马占兵,党洁,杨继辉,霍正浩,徐广贤. 基于慢病毒系统的双荧光标记多功能自噬流监测系统建立与应用 *[J]. 中国生物工程杂志, 2019, 39(5): 88-95.
[12] 胡瞬,易有金,胡涛,李福胜. mRNA疫苗的开发及临床研究进展[J]. 中国生物工程杂志, 2019, 39(11): 105-112.
[13] 韩亚丽,杨冠恒,陈雁雯,龚秀丽,张敬之. 表达β-珠蛋白基因的安全性慢病毒载体的优化 *[J]. 中国生物工程杂志, 2018, 38(7): 50-57.
[14] 谭杨,刘胜,罗凤玲,章晓联. 结核分枝杆菌H37Rv刺激巨噬细胞后差异表达lncRNA分析及鉴定 *[J]. 中国生物工程杂志, 2018, 38(5): 1-9.
[15] 秦娇荣, 赵兆, 罗心梅, 李春阳. 基于mRNA 5'端TIR区二级结构优化提高重组sTNFα RI在大肠杆菌中的表达水平[J]. 中国生物工程杂志, 2018, 38(3): 62-69.